Home > Boards > US Listed > Biotechs > INSMED (INSM)

Good info: https://www.google.nl/amp/s/www.fool.com/amp/investing/2017/09/05/heres-why-insmed-incor

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
FTR Member Profile
 
Followed By 5
Posts 332
Boards Moderated 0
Alias Born 07/16/06
160x600 placeholder
Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020 PR Newswire (US) - 7/27/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 9:38:47 AM
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect... PR Newswire (US) - 7/24/2020 7:39:00 AM
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect... PR Newswire (US) - 7/24/2020 7:36:00 AM
New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patient... PR Newswire (US) - 7/7/2020 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 7/6/2020 8:00:00 AM
Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at AT... PR Newswire (US) - 6/24/2020 4:01:00 PM
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCF... PR Newswire (US) - 6/8/2020 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 6/5/2020 8:00:00 AM
Insmed to Present at Two June Conferences PR Newswire (US) - 5/26/2020 8:00:00 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 5/21/2020 4:10:30 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/21/2020 4:08:11 PM
Insmed to Showcase New Brensocatib Data at American Thoracic Society Virtual Clinical Trials Session PR Newswire (US) - 5/20/2020 9:29:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 4:02:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2020 10:59:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2020 8:32:02 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 5/7/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/5/2020 5:30:59 PM
Insmed Announces Pricing of Public Offering of Common Stock PR Newswire (US) - 5/5/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/4/2020 4:13:29 PM
Insmed Announces Proposed Public Offering of Common Stock PR Newswire (US) - 5/4/2020 4:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/30/2020 7:31:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2020 7:31:37 AM
Insmed Reports First Quarter 2020 Financial Results and Provides Business Update PR Newswire (US) - 4/30/2020 7:30:00 AM
Brensocatib (Formerly INS1007) to be Studied in Patients with Severe COVID-19 in Investigator-Initiated Trial PR Newswire (US) - 4/23/2020 6:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist